{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:31:19Z","timestamp":1791549079249,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lfs.2022.120560","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:32:05Z","timestamp":1650367925000},"page":"120560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Suppression of PCSK9\/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-9688","authenticated-orcid":false,"given":"Kehinde S.","family":"Olaniyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Areloegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1358863X16682107","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc. Med."},{"issue":"4","key":"10.1016\/j.lfs.2022.120560_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/jammr\/2019\/v30i430190","article-title":"Prevalence of PCOS with associated symptoms and complications at tertiary care hospital of Karachi","volume":"30","author":"Zafar","year":"2019","journal-title":"J. Adv. Med. Med. Res."},{"issue":"11","key":"10.1016\/j.lfs.2022.120560_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics"},{"issue":"7","key":"10.1016\/j.lfs.2022.120560_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.lfs.2022.120560_bb0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"12","key":"10.1016\/j.lfs.2022.120560_bb0030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120560_bb0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.fertnstert.2018.11.034","article-title":"ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome","volume":"111","author":"Marchesan","year":"2019","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2022.120560_bb0040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main PCOS phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil. Steril."},{"issue":"108","key":"10.1016\/j.lfs.2022.120560_bb0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.fertnstert.2017.09.034","article-title":"Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?","volume":"108","author":"Azziz","year":"2017","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.lfs.2022.120560_bb0050","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/jwh.2018.7162","article-title":"Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome","volume":"27","author":"Carmina","year":"2018","journal-title":"J. Women's Health"},{"issue":"4","key":"10.1016\/j.lfs.2022.120560_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/09513590.2016.1266474","article-title":"Prescribing exercise for prevention and treatment of gestational diabetes: review of suggested recommendations","volume":"33","author":"Bianchi","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2022.120560_bb0065","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","article-title":"Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis","volume":"92","author":"Shroff","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.lfs.2022.120560_bb0070","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12020-015-0797-1","article-title":"Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome","volume":"52","author":"Gao","year":"2016","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.lfs.2022.120560_bb0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2022.120560_bb0085","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120560_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"Polycystic ovarian syndrome: long-term health consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Seminars in Reproductive Medicine"},{"issue":"4","key":"10.1016\/j.lfs.2022.120560_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2022.120560_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"04","key":"10.1016\/j.lfs.2022.120560_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/2231-0770.191445","article-title":"Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome","volume":"6","author":"Dube","year":"2016","journal-title":"Avicenna J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.120560_bb0110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"9","key":"10.1016\/j.lfs.2022.120560_bb0115","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1177\/0300060519864493","article-title":"Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis","volume":"47","author":"Meng","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/CT:5:2:183","article-title":"NF-\u03baB in cardiovascular disease","volume":"5","author":"Jones","year":"2005","journal-title":"Cardiovasc. Toxicol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120560_bb0125","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79187-0","article-title":"Nuclear factor kappa B activation in cardiomyocytes by serum of children with obstructive sleep apnea syndrome","volume":"10","author":"Goldbart","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2022.120560_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062068","article-title":"Celastrol, an NF-\u03baB inhibitor, improves insulin resistance and attenuates renal injury in db\/db mice","volume":"8","author":"Kim","year":"2013","journal-title":"PloS one"},{"issue":"10","key":"10.1016\/j.lfs.2022.120560_bb0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/CS20090557","article-title":"Role of nuclear factor \u03baB in cardiovascular health and disease","volume":"118","author":"Van der","year":"2010","journal-title":"Clin. Science"},{"key":"10.1016\/j.lfs.2022.120560_bb0145","article-title":"Potential role of nuclear factor \u03baB in diabetic cardiomyopathy","volume":"652097","author":"Lorenzo","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2022.120560_bb0150","article-title":"Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-\u03baB","volume":"258","author":"Reddy","year":"2020","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.lfs.2022.120560_bb0155","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1194\/jlr.R026658","article-title":"The PCSK9 decade thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases","volume":"53","author":"Lambert","year":"2012","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.lfs.2022.120560_bb0160","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/ATVBAHA.115.305688","article-title":"Role of insulin in the regulation of proprotein convertase subtilisin\/kexin type 9. s","volume":"35","author":"Miao","year":"2015","journal-title":"thrombosis, and vascular biology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120560_bb0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3892\/etm.2017.4055","article-title":"PCSK9 as a therapeutic target for cardiovascular disease","volume":"13","author":"Zhang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-2123-9","article-title":"Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy","volume":"17","author":"Cao","year":"2019","journal-title":"Journal of translational medicine"},{"issue":"12","key":"10.1016\/j.lfs.2022.120560_bb0175","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein (a), PCSK9 inhibition, and cardiovascular risk: insights from the FOURIER trial","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamacardio.2020.3151","article-title":"Efficacy and safety of PCSK9 inhibition with evolocumab in reducing cardiovascular events in patients with metabolic syndrome receiving statin therapy: secondary analysis from the FOURIER randomized clinical trial","volume":"6","author":"Deedwania","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120560_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2022.120560_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2014.23","article-title":"Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans","volume":"4","author":"Fernandes","year":"2014","journal-title":"Nutrition and diabetes"},{"issue":"8","key":"10.1016\/j.lfs.2022.120560_bb0195","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/nu11081943","article-title":"The short-chain fatty acid acetate in body weight control and insulin sensitivity","volume":"11","author":"Gonz\u00e1lez Hern\u00e1ndez","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2022.120560_bb0200","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide-or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120560_bb0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1535370220913847","article-title":"Suppression of HDAC by sodium acetate rectifies cardiac metabolic disturbance in streptozotocin\u2013nicotinamide-induced diabetic rats","volume":"245","author":"Olaniyi","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98605-5","article-title":"Acetate rescues defective brain-adipose metabolic network in obese wistar rats by modulation of peroxisome proliferator-activated receptor-\u03b3","volume":"11","author":"Olaniyi","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.lfs.2022.120560_bb0215","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00018-012-0921-9","article-title":"Multiple roles of class I HDACs in proliferation, differentiation, and development","volume":"69","author":"Reichert","year":"2012","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.lfs.2022.120560_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.lfs.2022.120560_bb0225","first-page":"1","article-title":"Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid\u2014a familiar foe.","author":"Adeyanju","year":"2020","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.lfs.2022.120560_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115381","article-title":"Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS","volume":"411","author":"Olaniyi","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120560_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jnutbio.2018.08.018","article-title":"Sodium acetate and androgen receptor blockade improve gestational androgen excess-induced deteriorated glucose homeostasis and antioxidant defenses in rats: roles of adenosine deaminase and xanthine oxidase activities","volume":"62","author":"T.O. Usman TO","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2022.120560_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108929","article-title":"Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity","volume":"316","author":"Dangana","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.120560_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jnci\/95.1.67","article-title":"Insulin resistance and prostate cancer risk","volume":"95","author":"Hsing","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2022.120560_bb0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biochi.2021.02.004","article-title":"Rescue effect of sodium acetate in diabetes mellitus-associated testicular dysfunction is accompanied by PCSK9 modulation","volume":"184","author":"Olaniyi","year":"2021","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.lfs.2022.120560_bb0255","first-page":"2115","article-title":"Waist-to-height ratio (WHtR) and triglyceride to HDL-C ratio (TG\/HDL-c) as predictors of cardiometabolic risk","volume":"31","author":"Miralles","year":"2015","journal-title":"Nutr. Hosp."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0686-8","article-title":"Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China","volume":"17","author":"Zhu","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2022.120560_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0103-05822014000100010","article-title":"Metabolic syndrome and insulin resistance in obese adolescents","volume":"32","author":"Gobato","year":"2014","journal-title":"Rev. Paul. Pediatr."},{"issue":"9","key":"10.1016\/j.lfs.2022.120560_bb0270","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2018-02496","article-title":"Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome","volume":"104","author":"Dapas","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.lfs.2022.120560_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005549","article-title":"Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol","volume":"6","author":"Lawler","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2022.120560_bb0280","article-title":"Cardiovascular risk factors and atherogenic indices in an iranian population: Birjand east of Iran","volume":"12","author":"Kazemi","year":"2018","journal-title":"Clin. Med. Insights: Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120560_bb0285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2022.120560_bb0290","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2022.120560_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/129651","article-title":"Nitric oxide-related oxidative stress and redox status in health and disease","author":"Modun","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.lfs.2022.120560_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/gerona\/glv008","article-title":"Senescence-induced oxidative stress causes endothelial dysfunction","volume":"71","author":"Bhayadia","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol. Sex Differ."},{"issue":"6","key":"10.1016\/j.lfs.2022.120560_bb0310","first-page":"401","article-title":"Is menopause a risk factor for ischaemic heart disease in women","volume":"13","author":"Leuzzi","year":"2012","journal-title":"G. Ital. Cardiol. (Rome)"},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/2053369117749675","article-title":"Menopause and cardiovascular disease","volume":"24","author":"Newson","year":"2018","journal-title":"Post Reprod. health"},{"issue":"suppl1","key":"10.1016\/j.lfs.2022.120560_bb0320","article-title":"Low PCSK-9 serum levels do not predict insulin resistance in a racially admixed populationThe ELSA-Brasil","volume":"136","author":"Ramin-Mangata","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.lfs.2022.120560_bb0325","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1111\/jcmm.14586","article-title":"PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia\/reperfusion injury: benefits beyond lipid-lowering effects","volume":"23","author":"Palee","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"13","key":"10.1016\/j.lfs.2022.120560_bb0330","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","article-title":"PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-51","article-title":"Acetate supplementation modulates brain histone acetylation and decreases interleukin-1\u03b2 expression in a rat model of neuroinflammation","volume":"9","author":"Soliman","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.lfs.2022.120560_bb0340","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1271\/bbb.60668","article-title":"Improvement of obesity and glucose tolerance by acetate in type 2 diabetic otsuka long-Evans Tokushima fatty (OLETF) rats","volume":"71","author":"Yamashita","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0345","first-page":"1","article-title":"Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans","volume":"9","author":"M\u00fcller","year":"2019","journal-title":"Sci. Reports"},{"issue":"1","key":"10.1016\/j.lfs.2022.120560_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02013-5","article-title":"A phenome-wide association study of genetically mimicked statins","volume":"19","author":"Li","year":"2021","journal-title":"BMC Medicine"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:58:12Z","timestamp":1758401892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522002600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":70,"alternative-id":["S0024320522002600"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120560","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of PCSK9\/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120560"}}